Literature DB >> 32651248

Management of patients with generalised myasthenia gravis and COVID-19: four case reports.

Annemarie Hübers1, Agustina M Lascano2, Patrice H Lalive3.   

Abstract

Entities:  

Keywords:  immunology; myasthenia; virology

Mesh：

Year:  2020        PMID： 32651248     DOI： 10.1136/jnnp-2020-323565

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  18 in total

1.  COVID-19 in patients with myasthenia gravis: Epidemiology and disease course.

Authors:  Pietro Businaro; Gloria Vaghi; Enrico Marchioni; Luca Diamanti; Sebastiano Arceri; Paola Bini; Elena Colombo; Giuseppe Cosentino; Enrico Alfonsi; Alfredo Costa; Sabrina Ravaglia; Giulia Mallucci; Elena Ballante; Diego Franciotta; Matteo Gastaldi
Journal:  Muscle Nerve       Date:  2021-06-12       Impact factor: 3.852

Review 2.  COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.

Authors:  Arens Taga; Giuseppe Lauria
Journal:  J Peripher Nerv Syst       Date:  2022-03-14       Impact factor: 5.188

3.  Perspectives of Neuro-COVID: Myasthenia.

Authors:  Josef Finsterer; Fulvio A Scorza
Journal:  Front Neurol       Date:  2021-02-26       Impact factor: 4.003

Review 4.  Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.

Authors:  Giuliana Galassi; Alessandro Marchioni
Journal:  Acta Neurol Belg       Date:  2021-04-02       Impact factor: 2.396

5.  Case series of COVID-19 in patients with myasthenia gravis: a single institution experience.

Authors:  Sven Županić; Martina Perić Šitum; Maja Majdak; Mirna Karakaš; Silvio Bašić; Davor Sporiš
Journal:  Acta Neurol Belg       Date:  2021-04-01       Impact factor: 2.396

Review 6.  [Neuroimmunology of COVID-19].

Authors:  Thomas Skripuletz; Nora Möhn; Christiana Franke; Harald Prüß
Journal:  Nervenarzt       Date:  2021-03-02       Impact factor: 1.214

Review 7.  Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic.

Authors:  Dario Ricciardi; Silvia Casagrande; Francesco Iodice; Bianca Orlando; Francesca Trojsi; Giovanni Cirillo; Marinella Clerico; Marco Bozzali; Letizia Leocani; Gianmarco Abbadessa; Giuseppina Miele; Gioacchino Tedeschi; Simona Bonavita; Luigi Lavorgna
Journal:  Neurol Sci       Date:  2021-08-26       Impact factor: 3.307

Review 8.  New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.

Authors:  Shitiz Sriwastava; Medha Tandon; Saurabh Kataria; Maha Daimee; Shumaila Sultan
Journal:  J Neurol       Date:  2020-10-12       Impact factor: 4.849

9.  Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up.

Authors:  Julia V Wanschitz; Manuela Kaml; Bettina Pfausler; Raimund Helbok; Sophie Wildner; Gerlig Widmann; Sabina Sahanic; Florian Deisenhammer; Wolfgang N Löscher; Markus Reindl; Judith Löffler-Ragg; Ronny Beer
Journal:  J Neurol       Date:  2020-11-20       Impact factor: 6.682

10.  Muscle involvement in SARS-CoV-2 infection.

Authors:  Lea Pitscheider; Mario Karolyi; Francesco R Burkert; Raimund Helbok; Julia V Wanschitz; Corinne Horlings; Erich Pawelka; Sara Omid; Marianna Traugott; Tamara Seitz; Alexander Zoufaly; Elisabeth Lindeck-Pozza; Ewald Wöll; Ronny Beer; Stefanie Seiwald; Rosa Bellmann-Weiler; Harald Hegen; Wolfgang N Löscher
Journal:  Eur J Neurol       Date:  2020-10-25       Impact factor: 6.288
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.